Material Type

• Blood (whole) (2)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Dried whole blood (3)
• Isolated peripheral blood mononuclear cells (non viable) (1)
• Plasma (double spun) (1)
• Plasma (single spun) (3)
• Saliva (3)
• Serum (4)
• Sputum (1)
• Swab medium (3)
• Urine (random) (1)

Microscopic Assessment

• Not applicable (6)

Storage Temperature

• -85°C to -60°C (6)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (1)
• Clinical records (5)
• Followup records (3)
• Genomic datasets (1)
• Microbiological results (4)
• Participant Ethnicity (1)
• Physiological/biochemical measurements (2)
• Pre-analytical data (3)
• Quality indicators (2)
• Survey data (3)
• Treatment records (1)

Timeframe

• 0 - 3 months (5)
• 3 - 6 months (1)
• > 6 months (1)

Participant Count

• 11 - 100 (2)
• 101 - 500 (3)
• 1001 - 3000 (1)

Sex

• Both sexes (6)

Age Range

• Young adult (18 - 40 years) (6)

Biobank Services

• Ability to recontact (2)
• Cell culture (1)
• Data analytics (2)
• Infectious strain isolation (1)

Collection Type

• (1)
• Case-control (2)
• Disease specific (3)

Consent Restriction

• No Commercial restriction (6)
• No Disease area restriction (6)
• No Genetic analysis restriction (4)
• No Human genetic analysis restriction (5)
• No restrictions (1)
• No Project specific restriction (6)
• No Scope of use restriction (4)

Collection Status

• Completed (3)
• In progress (2)
• Not-started (1)

Access Condition

• Open to applicants (6)

Country

• Belgium (1)
• France (1)
• Kenya (2)
• Peru (1)
• South Africa (1)

County